Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome
- 31 May 2007
- journal article
- review article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 46 (5), 935-946
- https://doi.org/10.1016/j.jhep.2007.02.001
Abstract
No abstract availableThis publication has 76 references indexed in Scilit:
- 114 Randomized, double-blind, placebo-controlled trial evaluating norfloxacin in the primary prophylaxis of spontaneous bacterial peritonitis in cirrhotics with renal impairment, hyponatremia or severe liver failureJournal of Hepatology, 2006
- A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitisHepatology, 2005
- Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitisJournal of Hepatology, 2004
- Assessing renal function in cirrhotic patients: Problems and pitfallsAmerican Journal of Kidney Diseases, 2003
- Hemodynamic and humoral changes after liver transplantation in patients with cirrhosisHepatology, 1993
- LONG-TERM SURVIVAL AND RENAL FUNCTION FOLLOWING LIVER TRANSPLANTATION IN PATIENTS WITH AND WITHOUT HEPATORENAL SYNDROMETransplantation, 1991
- Increased circulating calcitonin gene-related peptide (CGRP) in cirrhosisJournal of Hepatology, 1991
- Urinary excretion of 6-keto-prostaglandin F1α, thromboxane B2 and prostaglandin E2 in cirrhosis with ascites: Relationship to functional renal failure (hepatorenal syndrome)Journal of Hepatology, 1986
- Sympathetic nervous activity, renin‐angiotensin system and renal excretion of prostaglandin E2 in cirrhosis. Relationship to functional renal failure and sodium and water excretionEuropean Journal of Clinical Investigation, 1983
- Systemic and Renal Hemodynamics in Oliguric Hepatic Failure: Effect of Volume Expansion*JCI Insight, 1967